Key result
eCPR halts refractory ventricular tachyarrhythmia and bridges to diagnosis in a pediatric Brugada syndrome case.
Why the study?
The use of eCPR in refractory ventricular tachyarrhythmia from Brugada Syndrome is not well characterized in the pediatric literature.
eCPR can serve as an effective rescue therapy and bridge to definitive diagnosis in pediatric patients experiencing refractory ventricular tachyarrhythmia due to Brugada Syndrome.
May support eCPR rescue in pediatric refractory Brugada VT; hypothesis-generating and requires prospective trials before adoption.
Introduction: Children with refractory ventricular tachyarrhythmia (VT) represent a minority of pediatric cardiac arrests with prolonged conventional cardiopulmonary resuscitation (cCPR). Extracorporeal CPR (eCPR) is a rescue therapy when spontaneous circulation is not achieved with cCPR. Although Brugada Syndrome is a known etiology of VT, the use of eCPR in refractory VT from Brugada Syndrome is not well characterized in pediatric literature. Here, we present the second such described use of pediatric eCPR. Description: A 7 year-old previously healthy male presents with nocturnal episodes of abnormal breathing and movement. Although initially vitally stable with a reassuring exam, telemetry demonstrates self-resolving runs of polymorphic VT, ultimately progressing to pulseless cardiac arrest. Over the initial hour of resuscitation, he receives 4 defibrillations, epinephrine, amiodarone, magnesium, and calcium for refractory VT transiently converting to normal sinus rhythm. eCPR activation is sought for ongoing VT. In the intensive care unit, he demonstrates right-sided ST changes with bradycardia and normal QTc, and receives 9 additional defibrillations and isoproterenol for suspected Brugada Syndrome. Following peripheral cannulation to VA ECMO, he demonstrates immediate cessation of VT. The first 48 hours post-arrest are absent of VT recurrence, including isoproterenol wean. He requires aggressive thermoregulation via ECMO circuit and external cooling devices to maintain normothermia. Temperatures normalize 120 hours post-arrest, after which a Procainamide challenge is pursued without provocation of diagnostic ECG findings. Following heavy sedation during a subsequent clamp trial on ECMO day 6, he develops characteristic Brugada Type I ECG changes with bradycardia and is initiated on quinidine prior to ECMO decannulation 24 hours later. Discussion: Brugada Syndrome is a channelopathy with characteristic clinical features including stereotyped ECG abnormalities and classic environmental triggers (e.g. excess vagal tone, fevers, antiarrhythmics). In this case, the use of pediatric eCPR served to acutely manage cardiac arrest secondary to refractory VT and as a bridge to definitive diagnosis of Brugada Syndrome. Relevant diagnostic and management features for the intensivist team will be reviewed.
No takes yet. Share an insight, caveat, or question.
Pian et al. (2026) studied this question. Extracorporeal CPR provided immediate cessation of refractory ventricular tachyarrhythmia and served as a bridge to definitive diagnosis in a 7-year-old child with Brugada Syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: